Skip to main content
. 2019 Dec 10;11(12):1987. doi: 10.3390/cancers11121987

Figure 2.

Figure 2

Single and multiple dose area under the concentration time curve (AUC0-24h) of BAY 1125976 in the QD (A) and the BID (B) schedule, including patients at the 60 mg BID expansion cohort, showing dose linearity for both schedules. C, cycle; D, day; Exp, expansion cohort.